OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
15/02/2025
Voltar para busca
Dado oficial do USPTO
DEGLUSTEROL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
15/02/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
13/07/2023
Data de registro
09/04/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/04/2024
Última transação
15/02/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
KR
Examinador
HUDSON, TAMARA
Unidade examinadora
L40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
CAREGEN CO., LTD.
Representantes
Miriam D. Trudell Davis Graham & Stubbs LLC
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Biomedical compoundspeptides for industrial purposes; oligopeptides for industrial purposes; biomedical compoundspeptide substrates for scientific purposes; biomedical compoundspeptides for laboratory or research useother than for medical purposes; peptides being raw materials for industrial use for dietetic purposesother than for medical purposes; proteins for use in the manufacture of food supplements; proteins for the food industry; enzymes for industrial purposes; proteins for industrial use; proteins being raw material for industrial use; proteins for use in the manufacture of food and beverages; proteins for use in manufacture; proteins for use in the manufacture of cosmetics; chemicals used in industry and science; biochemical preparations for scientific purposes; biomedical compoundssynthetic peptides for use in the manufacture of food supplements for blood sugar management; cultures of microorganismsother than for medical and veterinary use; chemical additives for use in the manufacture of food; enzymes for the food industry; amino acids for industrial purposesfor laboratory or research use
Classe 5
Nutraceutical preparations for blood sugar control; nutraceuticals for use as a dietary supplement; biochemical preparations for medical or veterinary purposes for the treatment of diabetes; biotechnological preparations for medical purposes for the treatment of diabetes; powdered nutritional supplement drink mixes; pharmacological preparations for skin care; pharmaceuticals for the treatment of diabetes; medical preparations for slimming purposes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hyperlipidemia; anti-diabetic pharmaceuticals; pharmaceutical preparations for health care for the treatment of diabetes; pharmaceutical preparations for the prevention of diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for treating hypoglycemia; hypoglycemic agents; synthetic peptides for pharmaceutical purposes for the treatment of diabetes; medicines for human purposes for the treatment of diabetes; seaweed-based dietary supplements for diabetics; vegetables-based dietary supplements for diabetics; dietary supplements for diabetics based on Chinese matrimony vine; dietary supplements for diabetics based on the root of arrowroots; dietary supplements for diabetics based on Solomon's seal; meat-based dietary supplements for diabetics; whey-based dietary supplements for diabetics; dietary supplements for diabetics based on processed oils and fats for food; dietary supplements for diabetics based on preserved fish; dietary supplements for diabetics based on processed algae
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/01/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
26/01/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
25/01/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/01/2025
FIMP
FINAL DISPOSITION PROCESSED
03/01/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/11/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
14/11/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/11/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/11/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
20/10/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
09/04/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/04/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/01/2024
PUBO
PUBLISHED FOR OPPOSITION
23/01/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/01/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/12/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/12/2023
RFNT
REFUSAL PROCESSED BY IB
07/11/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
13/10/2023
RFRR
REFUSAL PROCESSED BY MPU
13/10/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
28/09/2023
CNRT
NON-FINAL ACTION WRITTEN
27/09/2023
DOCK
ASSIGNED TO EXAMINER
26/09/2023
MAFR
APPLICATION FILING RECEIPT MAILED
09/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/09/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
31/08/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DEGLUSTEROL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.